News and Comments

THREE SMALL BIOTECH FIRMS IN THE SPOTLIGHT

  Wednesday, July 31, 2013

Three biotechnology firms with market caps below $1billion have been recently put in the spotlight; SYNTA (SNTA) with a market cap of 535.54 million, ARRAY (ARRY) with a market cap of 774.22 million, and VANDA (VNDA) with a market cap of 320.45 million. More...


Recent Postings


Archive


Tags

Agenus (AGEN ABBVIE (ABBV) INNOVIVA (INVA) ISIS (ISIS) Endometrial Cancer Auspex (ASPX) Sanofi (SNY) Elan (ELN) ADVENTRIX (ANX) Jazz Pharmaceuticals (JAZZ) NANTKWEST (NK) CEMPRA (CEMP) Human Longevity (HLI) galapagos (GLPG) Global Cell Therapeutics (GBT) Regeneron (REGN) Biogen Idec (BIIB) SYNTA (SNTA) Ionis (IONS) Seattle Genetics (SGEN) Human Genome Sciences (HGSI) Editas (EDIT) Prosensa (RNA) Adaptimmune (ADAP) GlaxoSmithKline (GSK) Rapamune Merck (MRK) JUNO (JUNO) Anacor (ANAC) NEUROCRINE (NBIX) Incyte (INCY) MODERNA SUNESIS PHARMACEUTICALS (SNSS) Array Pharmaceuticals (ARRY) Ridaforolimus Sanofi (SNA) Exelixis (EXEL) Intrexon (XON) C4 Therapeutics Trastuzumab-DM1 Theravance Bio Pharma (TBPH) Revlimid (lenolidamide) Xoma (XOMA) SERES THERAPEUTICS (MCRB) Vitae Pharmaceuticals (VTAE) KITE (KITE) Biocryst (BCRX) NEKTAR (NKTR)) Dynavax (DVAX) Amgen (AMGN) Agenus (AGEN) ACADIA (ACAD) Cytokinetics (CYTK) Mirati Therapeutics (MRTX) KERYX (KERX) Sanofi-Aventis (SAN) Alder Biopharmaceuticals (ALDR) PORTOLA (PTLA) Gilead (GILD) Roche (RHHBY) Prolor Biotech (PBTH) Ariad (ARIA) RenenxBio (RGNX) Sarepta (SRPT) Telaprevir AstraZeneca (AZN) ARGOS (ARGS) PTC Therapeutics (PTCT) Intermune (ITMN) CompuGen (CGEN) Intercept (ICPT) TOKAI (TKAOI) AERIE PHARMACEUTICALS Ziofpharm (ZIOP) Vertex (VRTX) Sangamo (SGMO) Abbott Laboratories (ABT) Roche (ROCHE) Bellicum (BLCM) REGULUS (RGLS) LEXICON (LXRX) HALOZYME (HALO) OncoCyte (OCX) AGOS (ARGS) Genentech GUARDIAN HEALTH OSI (OSIP) Advaxis (ADXS) JOUNCE THERAPEUTICS (JNCE) Aimmune Therapeutics (AIMT) ImmunoGen (IMGN) VANDA (VNDA) Tysabri Ocular Therapeutix (OCUL) Onyx (ONXX) Alnylam (ALNY) ZALTRAP™ Herceptin IDERA (IDRA) Theravance (THRX) ARCA (ABIO) BIOMARIN (BMRN) Micromet (MITI) Spike Therapeutics (ONCE) Idenix (IDIX) Anadys (ANDS) Bristol-Myers Squibb (BMY) Galena (GALE) Dendreon (DNDN) Zerenex Sequenom (SQNM) Velcade (bortezomib) Illumina (ILMN) Benlysta (belimumab) Pluristem (PSTI) Inovio (INO) Valeant Pharmaceuticals International (VRX) CRISPR Therapeutics (CRSP) NOVOCURE (NVCR) Multiple Myeloma